Peru Sessions 2023

Held on November 16 and 17, 2023 in the Good Hope Clinic Auditorium, Lima, Peru!

The XLVII SOLACI 2023 Regional Sessions (16th Andean Region) was held in Lima, Peru and presented a high-level scientific program with important national and Latin American guests who shared their knowledge and experiences over two days of intense academic activity

The Peru Sessions 2023 were organized by SOLACI together with the Peruvian Society of Hemodynamics and Endovascular Interventionism (SOPHIE), and was aimed at interventional cardiologists, clinical cardiologists, technicians and nurses in hemodynamics, and anyone who wanted to update and grow professionally.

We thank the local scientific society for its invaluable contribution to holding these Sessions, the medical industry and all the attendees who were part of this important event.


Discover the best contents of the Peru 2023 Conference



Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Previous article
Next article

More articles by this author

Call For Science SOLACI & SBHCI 2026 – Submit Your Work!

We invite you to submit scientific papers and challenging clinical cases for the SOLACI & SBHCI 2026 Congress, taking place from July 29 to...

FAC Webinar | CTEPH: one disease, three strategies, one team,

The Latin American Society of Interventional Cardiology (SOLACI) invites you to participate in the upcoming webinar organized by the Heart Failure Committee of the...

Mourning the passing of Dr. Eugene Braunwald

From the Latin American Society of Interventional Cardiology (SOLACI), we deeply regret the passing of Dr. Eugene Braunwald, a central figure in the development...

2nd Webinar of the COMPLICAT 2026 Course: Update on “Shunts” with International Experts

The congenital heart disease area of SOLACI, in collaboration with SECARDIOPED, invites the medical community to participate in the 2nd Webinar of the COMPLICAT...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

SCAI 2026 | SELUTION DeNovo subanalysis: Use of sirolimus-eluting balloon in acute coronary syndrome

Percutaneous coronary intervention (PCI) with drug-eluting stent (DES) implantation remains the predominant strategy in the setting of acute coronary syndrome (ACS). However, in recent...

Beyond TAVI: Cardiac Rehabilitation as a Determinant of Clinical Outcomes

Aortic stenosis is an increasingly prevalent condition associated with population aging, with a prevalence of approximately 3.4% in individuals over 75 years of age...

Comparative outcomes between transaxillary approach and thoracotomy-based approaches in TAVI with alternative access

TAVI has become the standard treatment for high-risk aortic stenosis. When transfemoral access is not feasible (approximately 10–15%), alternative approaches are used: transaxillary (subclavian...